NCCAM DHEA/Aging Trials In Development, Intramural Director Says
This article was originally published in The Tan Sheet
Executive Summary
NCCAM's Division of Intramural Research is composing study protocols to look at DHEA's effect on age-related health defects, Clinical Director Marc Blackman, MD, said at an advisory council meeting in Bethesda, Md. May 31.
You may also be interested in...
Mistletoe-Drug Interactions Will Be Subject Of NCCAM Intramural Study
The National Center for Complementary & Alternative Medicine's intramural division plans to study potential interactions between mistletoe and the cancer drug gemcitabine (Eli Lilly's Gemzar)
Supplement Marketing Strategies To Seniors Slated For Senate Cmte. Debate
The Senate Select Committee on Aging will discuss marketing and distribution strategies for health care products targeted to the elderly at a hearing tentatively scheduled for Sept. 10.
NCCAM
Applications for director of Office of Intramural Research's Office of Clinical & Regulatory Affairs due July 16. OCRA director will be responsible for developing and overseeing clinical trials, ensuring ethical and regulatory compliance, submitting INDs to FDA and staff recruitment. Intramural Research Clinical Director Marc Blackman, MD, has said he wants office's infrastructure in place by May 2002 (1"The Tan Sheet" June 4, p. 5)